CDX | SJNK | CDX / SJNK | |
Gain YTD | 8.389 | 2.621 | 320% |
Net Assets | 230M | 4.41B | 5% |
Total Expense Ratio | 0.25 | 0.40 | 63% |
Turnover | 0.00 | 54.00 | - |
Yield | 11.66 | 7.43 | 157% |
Fund Existence | 3 years | 13 years | - |
CDX | SJNK | |
---|---|---|
RSI ODDS (%) | N/A | 3 days ago34% |
Stochastic ODDS (%) | 3 days ago76% | 3 days ago31% |
Momentum ODDS (%) | 3 days ago65% | 3 days ago54% |
MACD ODDS (%) | 3 days ago57% | 3 days ago43% |
TrendWeek ODDS (%) | 3 days ago64% | 3 days ago50% |
TrendMonth ODDS (%) | 3 days ago82% | 3 days ago50% |
Advances ODDS (%) | 4 days ago81% | 6 days ago51% |
Declines ODDS (%) | 6 days ago63% | 26 days ago45% |
BollingerBands ODDS (%) | 3 days ago57% | 4 days ago32% |
Aroon ODDS (%) | N/A | 3 days ago47% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MSEGX | 56.07 | -0.44 | -0.78% |
Morgan Stanley Inst Growth A | |||
ZDIIX | 25.89 | -0.22 | -0.84% |
Zacks Dividend Institutional | |||
RLBEX | 35.57 | -0.31 | -0.86% |
American Funds American Balanced R4 | |||
JACBX | 18.41 | -0.25 | -1.34% |
JHancock Mid Cap Growth I | |||
GCLLX | 16.17 | -0.22 | -1.34% |
Goldman Sachs Enhanced U.S. Equity C |
A.I.dvisor tells us that SJNK and IHRT have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SJNK and IHRT's prices will move in lockstep.
Ticker / NAME | Correlation To SJNK | 1D Price Change % | ||
---|---|---|---|---|
SJNK | 100% | -0.24% | ||
IHRT - SJNK | 27% Poorly correlated | +3.75% | ||
CCO - SJNK | 25% Poorly correlated | -5.17% |